On this page of StockholderLetter.com we present the latest annual shareholder letter from ROCKET PHARMACEUTICALS, INC. — ticker symbol RCKT. Reading current and past RCKT letters to shareholders can bring important insights into the investment thesis.

 •  4/6/2026 Letter Continued (Full PDF)
 •  5/1/2023 RCKT Stockholder Letter
 •  4/29/2024 RCKT Stockholder Letter
 •  4/30/2025 RCKT Stockholder Letter
 •  RCKT Benford's Law Stock Score = 87

RCKT Shareholder/Stockholder Letter Transcript:

ROCKET PHARMACEUTICALS, INC. (RCKT) annual report filed on form 10k

4/6/2026 Letter Continued (Full PDF)

 

Nothing in StockholderLetter.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy.